204 related articles for article (PubMed ID: 27514728)
1. A new survivin tracer tracks, delocalizes and captures endogenous survivin at different subcellular locations and in distinct organelles.
Beghein E; Van Audenhove I; Zwaenepoel O; Verhelle A; De Ganck A; Gettemans J
Sci Rep; 2016 Aug; 6():31177. PubMed ID: 27514728
[TBL] [Abstract][Full Text] [Related]
2. Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cells.
Jiang X; Wilford C; Duensing S; Munger K; Jones G; Jones D
J Cell Biochem; 2001 Aug 1-9; 83(2):342-54. PubMed ID: 11573250
[TBL] [Abstract][Full Text] [Related]
3. Design and screening of a chimeric survivin-specific nanobody and its anticancer activities in vitro.
Zhang N; Guo H; Zheng W; Wang T; Ma X
Anticancer Drugs; 2016 Oct; 27(9):839-47. PubMed ID: 27362789
[TBL] [Abstract][Full Text] [Related]
4. Nuclear survivin has reduced stability and is not cytoprotective.
Connell CM; Colnaghi R; Wheatley SP
J Biol Chem; 2008 Feb; 283(6):3289-3296. PubMed ID: 18057009
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.
Dohi T; Beltrami E; Wall NR; Plescia J; Altieri DC
J Clin Invest; 2004 Oct; 114(8):1117-27. PubMed ID: 15489959
[TBL] [Abstract][Full Text] [Related]
6. Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein.
Kang BH; Xia F; Pop R; Dohi T; Socolovsky M; Altieri DC
J Biol Chem; 2011 May; 286(19):16758-67. PubMed ID: 21454573
[TBL] [Abstract][Full Text] [Related]
7. A nanobody-based molecular toolkit for ubiquitin-proteasome system explores the main role of survivin subcellular localization.
Miao H; Liu C; Ouyang H; Zhang P; Liu Y; Zhang C; Deng C; Fu Y; Niu J; Zheng W; You F; Yang Y; Ma X
Front Bioeng Biotechnol; 2022; 10():952237. PubMed ID: 36743654
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of fibroblast growth factor 2-induced apoptosis involves survivin expression, protein kinase C alpha activation and subcellular translocation of Smac in human small cell lung cancer cells.
Xiao D; Wang K; Zhou J; Cao H; Deng Z; Hu Y; Qu X; Wen J
Acta Biochim Biophys Sin (Shanghai); 2008 Apr; 40(4):297-303. PubMed ID: 18401527
[TBL] [Abstract][Full Text] [Related]
9. Tuning Nanobodies' Bioactivity: Coupling to Ultrasmall Gold Nanoparticles Allows the Intracellular Interference with Survivin.
Stahl P; Kollenda S; Sager J; Schmidt L; Schroer MA; Stauber RH; Epple M; Knauer SK
Small; 2023 Aug; 19(33):e2300871. PubMed ID: 37035950
[TBL] [Abstract][Full Text] [Related]
10. PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin.
Cheng CW; Chow AK; Pang R; Fok EW; Kwong YL; Tse E
Am J Pathol; 2013 Mar; 182(3):765-75. PubMed ID: 23333752
[TBL] [Abstract][Full Text] [Related]
11. Survivin is released from cancer cells via exosomes.
Khan S; Jutzy JM; Aspe JR; McGregor DW; Neidigh JW; Wall NR
Apoptosis; 2011 Jan; 16(1):1-12. PubMed ID: 20717727
[TBL] [Abstract][Full Text] [Related]
12. Survivin monomer plays an essential role in apoptosis regulation.
Pavlyukov MS; Antipova NV; Balashova MV; Vinogradova TV; Kopantzev EP; Shakhparonov MI
J Biol Chem; 2011 Jul; 286(26):23296-307. PubMed ID: 21536684
[TBL] [Abstract][Full Text] [Related]
13. Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.
Lopergolo A; Tavecchio M; Lisanti S; Ghosh JC; Dohi T; Faversani A; Vaira V; Bosari S; Tanigawa N; Delia D; Kossenkov AV; Showe LC; Altieri DC
Cancer Res; 2012 Jul; 72(13):3251-9. PubMed ID: 22586065
[TBL] [Abstract][Full Text] [Related]
14. [Subcellular localization of survivin in non-small cell lung cancer].
He L; Hou M; Zhang J; Xu N; Chen P
Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
[TBL] [Abstract][Full Text] [Related]
15. Withanone as an inhibitor of survivin: a potential drug candidate for cancer therapy.
Wadegaonkar VP; Wadegaonkar PA
J Biotechnol; 2013 Oct; 168(2):229-33. PubMed ID: 23994265
[TBL] [Abstract][Full Text] [Related]
16. [Obtaining of the affinity purified antibodies against survivin for the structure functional study of the protein].
Akhidova EV; Volkova TD; Koroev DO; Yakupov IIu; Kalintseva MV; Zavalishina LE; Kaplun AP; Zharskaia OO; Zatsepina OV; Vol'pina OM
Bioorg Khim; 2013; 39(3):326-37. PubMed ID: 24397031
[TBL] [Abstract][Full Text] [Related]
17. The N-terminus of survivin is a mitochondrial-targeting sequence and Src regulator.
Dunajová L; Cash E; Markus R; Rochette S; Townley AR; Wheatley SP
J Cell Sci; 2016 Jul; 129(14):2707-12. PubMed ID: 27246243
[TBL] [Abstract][Full Text] [Related]
18. Survivin Small Molecules Inhibitors: Recent Advances and Challenges.
Albadari N; Li W
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771042
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer.
Riolo MT; Cooper ZA; Holloway MP; Cheng Y; Bianchi C; Yakirevich E; Ma L; Chin YE; Altura RA
J Biol Chem; 2012 Mar; 287(14):10885-93. PubMed ID: 22334690
[TBL] [Abstract][Full Text] [Related]
20. The functional repertoire of survivin's tails.
Wheatley SP
Cell Cycle; 2015; 14(2):261-8. PubMed ID: 25607650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
